Is there any association between passive smoking and esophagitis in pediatrics?

Exposure to environmental tobacco smoke [ETS] is one of the major factors of predisposing children to develop several hazardous health problems. We decided to investigate the association between nicotinine, one of the nicotine metabolites and esophagitis in children with gastroesophageal reflux disease [GERD]. In a case control study 46 children suffering from esophagitis referred to endoscopy ward were recruited. The control group consisted of 45 healthy children. Urine samples were collected and urinary cotinine level [UCL] measured. The mean age of esophagitis and control groups were 5.11 +/- 2.93 and 6.72 +/- 2.8 respectively. Sixty children were passive smokers; 31 of them had non-smoker parents. In control group, 32 [71.1%] children and in esophagitis group 29 [63%] children had non-smoker parents. The mean value of UCL in patients suffering from esophagitis was significantly higher than those in normal group [P=0.04, 24.98 +/- 6.4 ng/ml vs. 15.16 +/- 3.9 ng/ml]. Considering 50ng/ml as a cutoff point for UCL, it was significantly higher in passive smoker group than in non smoker group [P=0.02]. The mean cotinine level differed significantly in esophagitis and control group. Our results indicate the increased risk of developing esophagitis in children with ETS exposure

[Detection and analysis of BTNL2 gene mutations in patients diagnosed with skin sarcoidosis]

Sarcoidosis is a non-caseous granulomatous disease that can involve several organs such as lung, kidney, liver, heart and skin. In systemic sarcoidosis, skin lesions occur in 20-35% of patients. Cutaneous sarcoidosis with no systemic involvement was found in about 25% of patients. Mutation within Butyrophilin-like 2 [BTNL2] gene, rs2076530 was reported in systemic sarcoidosis. However, there is no report of evaluation of mutation in BTNL2 gene with the diagnosis of skin sarcoidosis. In this study ten patients with skin sarcoidosis were evaluated for the mutation of rs2076530 allele in exon 5 of BTNL2 gene. This assessment was performed by the single strand conformation polymerase chain reaction [SSCP-PCR] in which the existing mutations with positive shift were deteced using directl sequence analysis. Data from sequence analysis were evaluated and blusted by means of Choroms computer software. Our results showed the BTNL2 G->A transition of rs2076530 in seven patients and three patients were normal. This pilot study concludes the presence of a mutation at rs2076530 in exon 5 of BTNL2 gene in patients with skin sarcoidosis. Larger studies are needed to evaluate the role of this finding